Resources

Find the latest news about Femasys, including our media mentions, scientific publications, and more.

  • All
  • Media
  • Video
All
  • All
  • Media
  • Video

Femasys Selected by BioSpace as a 2023 Best Places to Work

November 14, 2022 BioSpace
View Now →

Femasys Targets Male Infertility with Updated Trial Design

November 3, 2022 BioWorld
View Now →

Femasys Inc. Provides Strategic Update on its FemaSeed® Pivotal Trial Design to Expedite Clinical Program Advancement

October 20, 2022 GlobeNewswire
View Now →

Femasys Inc. Announces the Appointment of Christine Thomas as Senior Vice President of Regulatory and Clinical Affairs

October 12, 2022 GlobeNewswire
View Now →

Femasys Inc. Announces Enrollment Completion for Stage 2 Study of FemBloc for Permanent Birth Control

October 6, 2022 GlobeNewswire
View Now →

Femasys Inc. Announces the Commercial Availability of FemCerv® for Cervical Cancer Screening and Expands Management Team

September 29, 2022 GlobeNewswire
View Now →

Media Kit

Effect change with our media kit—designed to help you optimize results with these helpful resources.

Download Kit